Endonovo Therapeutics, Inc. (OTCMKTS:ENDV – Get Free Report)’s stock price passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.00 and traded as high as $0.0001. Endonovo Therapeutics shares last traded at $0.00, with a volume of 0 shares.
Endonovo Therapeutics Stock Performance
Endonovo Therapeutics Company Profile
Endonovo Therapeutics, Inc, a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.
See Also
- Five stocks we like better than Endonovo Therapeutics
- 3 Best Fintech Stocks for a Portfolio Boost
- Meta Platforms May Ditch NVIDIA Chips—Here’s Why Investors Care
- Russell 2000 Index, How Investors Use it For Profitable Trading
- SoFi Technologies: From Fintech Speculation to Profit Engine
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Gold to $5,000? What Bank of America and UBS Have to Say
Receive News & Ratings for Endonovo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endonovo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
